Contact Us: 1-800-981-9883
The Complex World of Viral Hemorrhagic Fevers Viral hemorrhagic fevers (VHFs) represent a diverse spectrum of diseases impacting both animals and humans. VHFs are caused by five distinct families of RNA viruses: Filoviridae, Flaviviridae, Rhabdoviridae, Arenaviridae and Hantaviridae. These conditions manifest a wide range of symptoms, often marked by bleeding or hemorrhaging. The disease can…
Welcome to the final part of our series on Gain of Function Research (GOFR). This chapter highlights the National Science Advisory Board for Biosecurity’s (NSABB) newest recommendations, which seek to mitigate biosecurity and biosafety risks while advancing crucial research on potential pandemic pathogens. The COVID-19 pandemic, with conjectures about a potential laboratory leak, has reinvigorated…
COLA, a physician-directed organization whose purpose is to promote health and safety through accreditation and educational programs, is announcing the hiring of Jeannie St. Pierre as the new Director of Business Development. Jeannie St. Pierre brings with her a wealth of experience in anatomic and clinical pathology laboratories spanning over 25 years. Jeannie’s impressive career…
Welcome back to the fourth installment of our series focusing on Gain of Function Research (GOFR). In this entry, we turn our spotlight onto the current oversight frameworks in the United States designed to mitigate the biosecurity and biosafety risks inherent in GOFR. The Maze of U.S. Regulatory Policies on GOFR The United States boasts…
In this resource you will learn how to develop and implement an effective Quality Assessment Plan which:
Welcome back to our ongoing series exploring Gain of Function Research (GOFR). In this third installment, we venture onto the tightrope of balancing the inherent risks and benefits of GOFR, while acknowledging the challenges along the way. Piecing Together the Risk-Benefit Puzzle The controversy surrounding GOFR revolves around different perceptions of the associated risks and…
Welcome to the second chapter of our series exploring the complex world of Gain of Function Research (GOFR). In this post, we will shed light on the valuable benefits GOFR brings to the scientific table and explore the potential risks inherent in this innovative research. The Benefits of Gain of Function Research First and foremost,…
COLA, a leading laboratory accreditation organization, is proud to announce the appointment of Thomas J. Madejski, MD, to its esteemed Board of Directors. Dr. Madejski, a prominent and highly respected figure in the field of medicine, brings with him a wealth of experience and expertise, having been elected to the American Medical Association (AMA) Board…
Welcome to the first installment of our illuminating 5-part series on Gain of Function Research (GOFR). Throughout this series, we will demystify the intriguing world of GOFR, covering its definitions, origin, applications and potential risks and benefits. Additionally, we will review existing U.S. oversight frameworks that mitigate risks associated with GOFR and review the most…
